Questa traduzione è in preparazione. Nel frattempo mostriamo temporaneamente la versione originale in inglese.
Imprese · 23/04/19971 min di lettura
Positron Emission Tomography Drug Products; Draft Guidance for Industry on Content and Format of an Abbreviated New Drug Application; Availability
Traduzione automatica locale · Lingua originale della fonte
Riepilogo
The Food and Drug Administration (FDA) is announcing the availability of a draft guidance document entitled ``Guidance for Industry: Content and Format of an Abbreviated New Drug Application (ANDA)--Positron Emission Tomography (PET) Drug Products.'' This draft guidance is intended to assist applicants who wish to submit an ANDA for Fludeoxyglucose F18 Injection. The draft guidance is one of several topics to be discussed at an April 28, 1997, FDA workshop on PET radiopharmaceutical drug products. The agency is requesting comments on this draft guidance.
Lingua originale della fonte: Federal Register — Food and Drug AdministrationApri il comunicato originale →